Financial Results

LANXESS India incumbent MD Neelanjan Banerjee to lead India region

Thane, August 05, 2018: German specialty chemicals company LANXESS is establishing a new regional structure which will comprise the regions EMEA (Europe, Middle East and Africa), Americas (North and South America), APAC (Asia-Pacific) and Indiafor enhanced focus and growth in the new regions.

As part of the new organization, the newly formed India region will be headed by the then LANXESS India Managing Director &Country Representative, Neelanjan Banerjee starting September 1, 2018. He will assume these tasks in addition to his current function as head of the Advanced Industrial Intermediates business unit (BU AII) in India. Banerjee joined LANXESS in 2006 as head of the former Basic Chemicals business unit and the Saltigo business unit in India. He is based in Thane, India.

“India is an important region for LANXESS that offers a lot of potential,” said Matthias Zachert, Chairman of the Board of Management at LANXESS. “The new regional organization under the leadership of Neelanjan Banerjee is specifically geared toward driving growth in India in the coming years.”

LANXESS India

LANXESS India was incorporated in India on February 20, 2004, and is represented through all its twelve business units, operating out of its registered office in Thane and sales offices in New Delhi and Chennai with around 1000 employees across its operations. The company also has manufacturing facilities in India for five of its business units. The manufacturing sites are located in Nagda in Madhya Pradesh and Jhagadia in Gujarat. Production facilities for business units Liquid Purification Technologies (ion exchange resins), High Performance Materials (high tech plastics), Material Protection Products (biocides) and RheinChemie (polymer bound rubber chemicals and release agents) are operational in Jhagadia. The business unit Advanced Industrial Intermediates has production facilities both in Nagda and Jhagadia.

LANXESS has invested a sizeable amount in India over the years, in greenfield investments, acquisitions and in upgradation of assets, which validates the potential of the Indian chemical industry.

For more information on LANXESS India please go to www.lanxess.in

Corporate Comm India(CCI Newswire)

The Pharma Times News Bureau

Recent Posts

S.L. Raheja Hospital, Mahim Introduces Certificate Course In Wound Care Nursing

Mumbai, May 22, 2024: The Department of Nursing at S.L. Raheja Hospital, Mahim - A…

3 days ago

Dr. Agarwals Eye Hospital Supports Nutritional Well-being of Children with Vehicle Donation to Akshaya Patra Foundation in Hubli

Hubli, May 20, 2024: In a significant move to support child nutrition through effective logistical contributions,…

5 days ago

Gleneagles Hospital Mumbai Introduces Pediatric Bone Marrow Transplant (BMT) Facility

New Delhi, May 17, 2024: In response to the growing need for specialized pediatric care,…

1 week ago

Ramaiah Memorial Hospital Launches Novel Intra-Operative Radiation Therapy (IORT);

Achieves significant advancement in Cancer Treatment to Enhance Quality of Life  As per the National…

1 week ago

Two Complex Robotic Kidney Transplant Surgeries Successfully Performed at Fortis Hospital Bannerghatta Road

-An 11-year-old boy from Yemen and a 34-year-old man from Bengaluru, both suffered from end-stage…

1 week ago

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home2/theprkho/public_html/thepharmatimes.in/wp-includes/functions.php on line 5420